EAM
RVMD icon

Eagle Asset Management’s Revolution Medicines RVMD Stock Holding History

Eagle Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.35M Buy
+72,030
New +$3.14M 0.02% 401

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eagle Asset Management's RVMD Position: Q3 2024 in Review

Eagle Asset Management opened a new position in Revolution Medicines (RVMD) in Q3 2024: 72,030 shares worth $4.35M. The stake represents 0.02% of the portfolio and ranks #401 among its holdings.

255 funds tracked by Wall St. Rank hold RVMD as of Q3 2024.

  • Eagle Asset Management held 72,030 shares of Revolution Medicines worth $4.35M as of Q3 2024.
  • Revolution Medicines was a new Eagle Asset Management position in Q3 2024.
  • Revolution Medicines made up 0.02% of Eagle Asset Management's portfolio in Q3 2024, its #401 holding.
  • 255 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2024.

Based on Eagle Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.